Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (38 ops.)
Latest filing published 09 Sept 2026 for Entrada Therapeutics, Inc., €236k. Read the official filing
Filing timeline
BuySaleMPM BioVentures 2014, L.P.
Insider track record
Disclosed buys
0
Disclosed sells
38
Signal history
MPM BioVentures 2014, L.P.: trading record in brief
Filings by MPM BioVentures 2014, L.P. span 4 companies, the busiest being iTeos Therapeutics, Inc., Entrada Therapeutics, Inc. and Werewolf Therapeutics, Inc. Between 4 May 2021 and 9 September 2026, the trades on record add up to 43 filings.
The open-market record consists of 38 sales worth €17.8M, with no purchase. The rest of the record consists of 1 share grant. 2026 to date brings no purchases and 12 sales.
The record was last updated on 9 September 2026 with an open-market sale (€236k) in Entrada Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to MPM BioVentures 2014, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
38,500 shares@ US$7.110.11% mcap6.6% of flowCommon StockSEC:0001231919-26-001155:0
28,837 shares@ US$7.130.079% mcap5.0% of flowCommon StockSEC:0001231919-26-001155:2
192,500 shares@ US$7.410.55% mcap34.6% of flowCommon StockSEC:0001231919-26-001155:1
29,088 shares@ US$7.060.080% mcap5.0% of flowCommon StockSEC:0001231919-26-001143:0
25,131 shares@ US$7.190.070% mcap4.4% of flowCommon StockSEC:0001231919-26-001143:1
32,263 shares@ US$7.170.090% mcap5.6% of flowCommon StockSEC:0001231919-26-001143:2
38,922 shares@ US$7.200.11% mcap6.8% of flowCommon StockSEC:0001231919-26-001135:0
3,733 shares@ US$7.010.010% mcap0.6% of flowCommon StockSEC:0001231919-26-001135:1
44,259 shares@ US$6.990.12% mcap7.5% of flowCommon StockSEC:0001231919-26-001135:2
21,623 shares@ US$7.340.061% mcap3.8% of flowCommon StockSEC:0001231919-26-001107:0
26,522 shares@ US$7.540.077% mcap4.8% of flowCommon StockSEC:0001231919-26-001107:1
14,569 shares@ US$7.060.040% mcap2.5% of flowCommon StockSEC:0001231919-26-001107:2
59,277 shares@ US$0.896.0% of flowCommon StockSEC:0001231919-25-000575:0
60,733 shares@ US$0.986.8% of flowCommon StockSEC:0001231919-25-000565:0
64,331 shares@ US$0.836.2% of flowCommon StockSEC:0001231919-25-000551:0
52,627 shares@ US$0.935.6% of flowCommon StockSEC:0001231919-25-000534:0
90,951 shares@ US$0.9810.2% of flowCommon StockSEC:0001231919-25-000509:0
68,480 shares@ US$1.118.7% of flowCommon StockSEC:0001231919-25-000461:0
140,488 shares@ US$1.2219.8% of flowCommon StockSEC:0001231919-25-000441:0
86,936 shares@ US$1.4314.2% of flowCommon StockSEC:0001231919-25-000406:0
72,709 shares@ US$1.7214.3% of flowCommon StockSEC:0001231919-25-000374:0
630,191 shares@ US$8.0633.4% of flowCommon StockSEC:0001415889-25-013248:0
22,758 shares@ US$0.090.3% of flowCommon StockSEC:0001415889-25-011574:0
22,935 shares@ US$20.7712.7% of flowCommon StockSEC:0001415889-24-029141:0
4,158,964 shares0Common StockSEC:0001209191-23-034340:0
25 of 35 declarations
